Emulsifier
DEA-HYDROLYZED LECITHIN
Safety score Β· 0β100
Caution
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
Lecithin modified with diethanolamine (DEA). DEA-family ingredients are flagged for potential nitrosamine formation β largely deprecated.
DEA-hydrolyzed lecithin is formed by reacting hydrolyzed lecithin with diethanolamine. Secondary amines like DEA can react with nitrosating agents (nitrites, other nitrogen oxides) to form N-nitrosodiethanolamine (NDELA), an IARC Group 2B probable human carcinogen. The EU Cosmetics Regulation Annex III entry 60 restricts DEA-containing formulations and requires NDELA levels below 50 ppb in DEA-containing ingredients. California Proposition 65 lists NDELA. The SCCS has expressed concerns, and major cosmetic brands have phased out DEA derivatives. Lecithin itself is benign β the DEA modification is the issue.
Function
Skin benefits
- Modified lecithin β emulsifying and conditioning
- Derived from soy or egg lecithin
Known concerns
- Diethanolamine (DEA) derivative β nitrosamine formation risk with nitrosating agents
- DEA family restricted in EU cosmetics (Annex III entry 60 controls)
- California Prop 65 listed (NDELA)
- Falling out of favor industry-wide
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Related emulsifiers
Check your shelf
Find DEA-HYDROLYZED LECITHIN in your products.
Scan any cosmetic product with LuxSense to see if it contains DEA-HYDROLYZED LECITHIN and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.